A joint international research team has challenged the traditional "pollution haven" hypothesis—which suggests that companies ...

If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in Europe Scemblix ...